Fri12262014

Last updateTue, 23 Dec 2014 1pm

Back You are here: Home News Industry Headlines Valve Manufacturing Crane Co. Reports Fourth Quarter Results; Posts Record EPS in 2012

Valve Manufacturing

Crane Co. Reports Fourth Quarter Results; Posts Record EPS in 2012

Crane Co. reported fourth quarter 2012 earnings from continuing operations of $0.79 per share, compared to a net loss of $2.18 per share in the fourth quarter of 2011. Fourth quarter 2012 results included after-tax charges of $4 million, or $0.07 per share, associated with previously announced repositioning actions, as well as transaction-related costs of $4 million, or $0.07 per share.

Fourth quarter 2012 sales from continuing operations of $630 million increased $10 million, or 1.6%, compared to the fourth quarter of 2011, resulting entirely from core sales growth. Operating profit from continuing operations in the fourth quarter of 2012 was $76.2 million compared to an operating loss of $194.0 million in the fourth quarter of 2011. Excluding Special Items, fourth quarter 2012 operating profit from continuing operations increased 8.5% to $84.6 million compared to $78.0 million in the fourth quarter of 2011, and operating profit margin increased to 13.4%, compared to 12.6% in the fourth quarter of 2011.

Fourth quarter 2012 sales in the Fluid Handling segment declined $2.5 million, or 1%, driven primarily by weaker European end markets. Segment operating margin improved to 13.9%, reflecting improved execution, productivity gains and solid cost management. Fluid Handling order backlog was $327 million at December 31, 2012, compared to $331 million at September 30, 2012 and $314 million at December 31, 2011.

New Products

 

Valve Magazine Digital Edition

14 FALL CVR 160x214Inside the Fall 2014 issue…

• Market Outlook 2015
• Enhanced Oil Recovery
• Combined Cycle Power Plants
• Critical Role of Flanges

CLICK HERE TO REQUEST YOUR
DIGITAL EDITION PREVIEW EMAIL

men clomid nolvadex and deca buy steroids by credit card sciroxx steroids clenbuterol steroids